Cancer Genetics and Epigenetics 2024, Vol.12, No.6, 317-328 http://medscipublisher.com/index.php/cge 325 References Abdullah M., Meilany S., Trimarsanto H., Malik S.G., Sukartini N., Idrus F., Nursyirwan S.A., Muzellina V.N., Pribadi R.R., Utari A.P., Maulahela H., and Syam A.F., 2022, Genomic profiles of Indonesian colorectal cancer patients, F1000 Research, 11: 443. https://doi.org/10.12688/f1000research.109136.2 PMID: 37125020 PMCID: PMC10133825 Al-Joufi F.A., Setia A., Salem-Bekhit M.M., Sahu R.K., Alqahtani F.Y., Widyowati R., and Aleanizy F.S., 2022, Molecular pathogenesis of colorectal cancer with an emphasis on recent advances in biomarkers, as well as nanotechnology-based diagnostic and therapeutic approaches, Nanomaterials, 12(1): 169. https://doi.org/10.3390/nano12010169 PMID: 35010119 PMCID: PMC8746463 Baratti D., Kusamura S., Niger M., Perrone F., Milione M., Cattaneo L., Guaglio M., Bartolini V., Pietrantonio F., and Deraco M., 2020, Prognostic impact of primary Side and RAS/RAF mutations in a surgical series of colorectal cancer with peritoneal metastases, Annals of Surgical Oncology, 28(6): 3332-3342. https://doi.org/10.1245/s10434-020-09161-7 PMID: 32974694 Cao H., Liu X.Y., Chen Y., Yang P., Huang T.X., Song L.L., and Xu R.L., 2020, Circulating tumor DNA is capable of monitoring the therapeutic response and resistance in advanced colorectal cancer patients undergoing combined target and chemotherapy, Frontiers in Oncology, 10: 466. https://doi.org/10.3389/fonc.2020.00466 PMID: 32318348 PMCID: PMC7154135 Cao W.G., Xu Y.P., Chang L.P., Gong Y.H., Li L.R., Mo X.W., Zhang X., Lin G.L., Zhou J.L., Liu D., Yi Y.T., Dai P.P., Zhu C.C., Liu T., Chu Y.X., Guan Y.F., Chen Y.S., Wang J.Y., Xia X.F., Yang L., Yi X., and Cheng Y., 2019, Genotyping of circulating tumor DNA reveals the clinically actionable mutation landscape of advanced colorectal cancer, Molecular Cancer Therapeutics, 18(6): 1158-1167. https://doi.org/10.1158/1535-7163.MCT-18-1247 PMID: 31015309 Clarke P.A., Roe T., Swabey K., Hobbs S.M., McAndrew C., Tomlin K., Westwood, I., Burke, R., van Montfort R., and Workman P., 2019, Dissecting mechanisms of resistance to targeted drug combination therapy in human colorectal cancer, Oncogene, 38(25): 5076-5090. https://doi.org/10.1038/s41388-019-0780-z PMID: 30905967 PMCID: PMC6755994 Cragun D.L., Kechik J., and Pal T., 2018, Complexities of genetic screening and testing in hereditary colorectal cancer, Seminars in Colon and Rectal Surgery, 29(2): 90-97. https://doi.org/10.1053/J.SCRS.2018.06.001 Das P.K., Islam F., and Lam A.K., 2020, The roles of cancer stem cells and therapy resistance in colorectal carcinoma, Cells, 9(6): 1392. https://doi.org/10.3390/cells9061392 PMID: 32503256 PMCID: PMC7348976 Di Nicolantonio F., Vitiello P.P., Marsoni S., Siena S., Tabernero J., Trusolino L., Bernards R., and Bardelli A., 2021, Precision oncology in metastatic colorectal cancer-from biology to medicine, Nature Reviews Clinical Oncology, 18(8): 506-525. https://doi.org/10.1038/s41571-021-00495-z PMID: 33864051 Dimberg J., Andersson R.E., and Haglund S., 2020, Genomic profiling of stage II colorectal cancer identifies candidate genes associated with recurrence-free survival, tumor location, and differentiation grade, Oncology, 98(8): 575-582. https://doi.org/10.1159/000507118 PMID: 32408300 PMCID: PMC7592935 Durinikova E., Buzo K., and Arena S., 2021, Preclinical models as patients’ avatars for precision medicine in colorectal cancer: past and future challenges, Journal of Experimental and Clinical Cancer Research, 40(1): 185. https://doi.org/10.1186/s13046-021-01981-z PMID: 34090508 PMCID: PMC8178911 Gao X.H., Yu G.Y., Hong Y.G., Lian W., Chouhan H., Xu Y., Liu L.J., Bai C.G., and Zhang, W., 2019, Clinical significance of multiple gene detection with a 22-gene panel in formalin-fixed paraffin-embedded specimens of 207 colorectal cancer patients, International Journal of Clinical Oncology, 24(2): 141-152. https://doi.org/10.1007/s10147-018-1377-1 PMID: 30612269 Hassani B., Alizadeh R., Akouchekian M., Tameshkel F.S., and Niya M.H.K., 2023, Mutation analysis of KRAS and BRAF in Iranian colorectal cancer patients: a novel variant in exon 15 of BRAF, Asian Pacific Journal of Cancer Prevention, 24(11): 3665-3671. https://doi.org/10.31557/APJCP.2023.24.11.3665 PMID: 38019223 PMCID: PMC10772775 He S.Y., Li, Y.C., Wang, Y., Peng, H.L., Zhou C.L., Zhang C.M., Chen S.L., Yin J.F., and Lin M., 2022, Fecal gene detection based on next generation sequencing for colorectal cancer diagnosis, World Journal of Gastroenterology, 28(25): 2920-2936. https://doi.org/10.3748/wjg.v28.i25.2920. PMID: 35978873 PMCID: PMC9280739
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==